CompletedPhase 3

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

393 participantsStarted 2005-05-27

Plain-language summary

The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patient at least 18 years old * Patient has menses approximately monthly * Patient has at least a 6 month history of migraine and at least a 6 month history of menstrual migraine Exclusion Criteria: * Pregnant and/or nursing mother * Cardiovascular disease * Uncontrolled hypertension

What they're measuring

Percentage of patients with 2 hour pain relief: 4-point headache severity scale as recorded in patient diary

Trial details

NCT IDNCT00111722

SponsorOrganon and Co

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-02-15

View on ClinicalTrials.gov More Migraine trials